Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial

Evaluation of acute, subacute, and subchronic toxicity of a hepatoprotective herbal formulation

“…In our previous study, we formulated an herbal product for managing non-alcoholic fatty liver disease (NAFLD) and showed that it decreases the grade of the fatty liver and the serum level of hepatic enzymes [22] . This product contains seeds of Anethum graveolens L. (dill, family Apiaceae), leaves of Cynara scolymus L. (artichoke, family Asteraceae), flower of Citrus aurantium L. (bitter orange, family Rutaceae), seeds of Portulaca oleracea L. (purslane, family Portulacaceae), and seeds of Silybum marianum L. (milk thistle, family Asteraceae).…”